EA201491668A1 - Вакцины и способы для лечения болезни лайма у собак - Google Patents
Вакцины и способы для лечения болезни лайма у собакInfo
- Publication number
- EA201491668A1 EA201491668A1 EA201491668A EA201491668A EA201491668A1 EA 201491668 A1 EA201491668 A1 EA 201491668A1 EA 201491668 A EA201491668 A EA 201491668A EA 201491668 A EA201491668 A EA 201491668A EA 201491668 A1 EA201491668 A1 EA 201491668A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- vaccines
- dogs
- methods
- lime
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Согласно настоящему изобретению предложена иммуногенная композиция, содержащая антигенный фрагмент белка OspA Borrelia burgdorferi и химерный белок, содержащий антигенные фрагменты различных филотипов белка OspC Borrelia burgdorferi. Также предложены вакцины, содержащие иммуногенную композицию по изобретению, а также способы предотвращения болезни Лайма у собак и/или защиты собак от болезни Лайма с использованием вакцин.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261635031P | 2012-04-18 | 2012-04-18 | |
PCT/US2013/037063 WO2013158818A2 (en) | 2012-04-18 | 2013-04-18 | Vaccines and methods to treat lyme disease in dogs |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201491668A1 true EA201491668A1 (ru) | 2015-08-31 |
Family
ID=48193279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201491668A EA201491668A1 (ru) | 2012-04-18 | 2013-04-18 | Вакцины и способы для лечения болезни лайма у собак |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2838555A2 (ru) |
JP (1) | JP2015514776A (ru) |
CN (1) | CN104379164A (ru) |
AR (1) | AR090726A1 (ru) |
AU (1) | AU2013249229A1 (ru) |
BR (1) | BR112014025740A2 (ru) |
CA (1) | CA2870179C (ru) |
EA (1) | EA201491668A1 (ru) |
UY (1) | UY34745A (ru) |
WO (1) | WO2013158818A2 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3204404A4 (en) | 2014-10-08 | 2018-06-06 | Virginia Commonwealth University | Stage specific diagnostic antigens, assay and vaccine for lyme disease |
JP2021505560A (ja) * | 2017-12-04 | 2021-02-18 | インターベット インターナショナル ベー. フェー. | イヌライム病ワクチン |
CN110483624B (zh) * | 2019-08-22 | 2021-02-09 | 中国疾病预防控制中心传染病预防控制所 | 伽氏疏螺旋体OspA蛋白C端肽段及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4567043A (en) | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
US4567042A (en) | 1983-06-15 | 1986-01-28 | American Home Products Corporation | Inactivated canine coronavirus vaccine |
US6872550B1 (en) | 1991-07-11 | 2005-03-29 | Baxter Vaccine Ag | Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens |
CA2115554A1 (en) * | 1991-08-15 | 1993-03-04 | Yves Lobet | Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
WO2000006745A1 (en) | 1998-07-31 | 2000-02-10 | Gundersen Lutheran Medical Foundation, Inc. | Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
EP2283031B1 (en) * | 2008-05-02 | 2017-04-12 | Virginia Commonwealth University | Lyme disease vaccine |
WO2010132758A2 (en) * | 2009-05-14 | 2010-11-18 | Gomes-Solecki Maria J | Ospc-based diagnostic test for lyme disease |
EP3029073B1 (en) * | 2010-10-20 | 2019-09-04 | Virginia Commonwealth University | Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
-
2013
- 2013-04-16 UY UY0001034745A patent/UY34745A/es not_active Application Discontinuation
- 2013-04-17 AR ARP130101267A patent/AR090726A1/es unknown
- 2013-04-18 CN CN201380030342.1A patent/CN104379164A/zh active Pending
- 2013-04-18 AU AU2013249229A patent/AU2013249229A1/en not_active Abandoned
- 2013-04-18 CA CA2870179A patent/CA2870179C/en active Active
- 2013-04-18 WO PCT/US2013/037063 patent/WO2013158818A2/en active Application Filing
- 2013-04-18 EP EP13719257.1A patent/EP2838555A2/en not_active Withdrawn
- 2013-04-18 BR BR112014025740A patent/BR112014025740A2/pt not_active IP Right Cessation
- 2013-04-18 EA EA201491668A patent/EA201491668A1/ru unknown
- 2013-04-18 JP JP2015507162A patent/JP2015514776A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2013158818A2 (en) | 2013-10-24 |
CA2870179A1 (en) | 2013-10-24 |
AR090726A1 (es) | 2014-12-03 |
UY34745A (es) | 2013-11-29 |
EP2838555A2 (en) | 2015-02-25 |
BR112014025740A2 (pt) | 2017-07-04 |
AU2013249229A1 (en) | 2014-10-23 |
JP2015514776A (ja) | 2015-05-21 |
CA2870179C (en) | 2018-09-04 |
WO2013158818A3 (en) | 2014-04-17 |
CN104379164A (zh) | 2015-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123739T1 (el) | Αντισωματα anti-cd38 | |
CY1120772T1 (el) | ΜΕΤΑΛΛΑΓΜΕΝΑ ΘΡΑΥΣΜΑΤΑ OspA ΚΑΙ ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ ΣΧΕΤΙΚΕΣ ΜΕ ΑΥΤΑ | |
EA201790294A1 (ru) | Средства на основе флагеллина и применения, включающие эффективную вакцинацию | |
EA201791485A1 (ru) | Анти-cd47-антитела и их применения | |
MX348113B (es) | Genes ospa quimericos, proteinas, y metodos para usar los mismos. | |
EA201391457A1 (ru) | Белки, связывающиеся с bcma (cd269/tnfrsf17) | |
EA201401204A1 (ru) | Антитела к il-23p19 | |
EA201001491A1 (ru) | Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов | |
EA201792465A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
EA201401077A1 (ru) | Биспецифические антитела к человеческому tweak и человеческому il17 и их применения | |
EA201890548A1 (ru) | Антитела к il-23 | |
EA201391240A1 (ru) | Слитые белки и комбинированные вакцины, содержащие белок е и пилин а haemophilus influenza | |
EA201390772A1 (ru) | Новые соли и полиморфные формы афатиниба | |
UA118332C2 (uk) | Білок, що зв'язує антиген cd27l | |
EA201690159A1 (ru) | Способы и композиции для лечения рака | |
EA201792407A3 (ru) | Композиции, содержащие буфер, составы вакцин, которые содержат композиции, содержащие буфер, и пути их применения | |
EA201301107A1 (ru) | Моноклональные антитела против ингибитора пути тканевого фактора (tfpi) | |
CY1121734T1 (el) | ΜΕΤΑΛΛΑΓΜΕΝΑ ΘΡΑΥΣΜΑΤΑ OspA ΚΑΙ ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ ΣΧΕΤΙΚΕΣ ΜΕ ΑΥΤΑ | |
AR093620A1 (es) | Anticuerpos bmp-6 | |
BR112015020079A8 (pt) | Composições para cuidado oral | |
SG10201805646WA (en) | Angiopoietin-like 4 antibodies and methods of use | |
TW201613977A (en) | Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use | |
EA201491668A1 (ru) | Вакцины и способы для лечения болезни лайма у собак | |
WO2014018274A8 (en) | Compositions comprising chimeric ospa molecules and methods of use thereof | |
EA201290319A1 (ru) | Применение источника l3 и/или l5 в качестве вакцины или диагностического средства для паразитарного заболевания |